(Date:10/10/2008)...ALE, N.J., Oct. 10 /PRNewswire-FirstCall/ -- Synvi...t it has appointed William,(Bill) Federici, 49, to...ve,members., Mr. Federici joined West Pharmaceuti... Officer in August of 2003. Under his financial le...n to more than $1.0 billion from,$300 million. He ...
(Date:10/10/2008)...OND, Va., Oct. 10 /PRNewswire/ -- Do you think tha... get around town? Attend the October,17 open house...nd and,Vision Impaired, and see how instructors th...d productive, fulfilling lives through non-visual,...ated at 401 Azalea Avenue, is holding an open hous...
(Date:10/10/2008)... Upon the completion of a highly s...n of CDM Media proudly announces their next busine...nformation technology executives in healthcare. CD...ll launch May 10-12, 2009 at the Four Seasons Reso...onolulu, HI (PRWEB) October 11, 2008 -- Upon the c...
(Date:10/10/2008)...E, PA The American Nurses Credentialing Center (A... as a Magnet hospital. The news came via a confere...aff who broke out with cheers and applause., GMC ...tals and only 294 hospitals in the United States ...hospitals are eligible for this recognition., "Ac...
Breaking Medicine News(10 mins):Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2Health News:Geisinger Medical Center earns prestigious Magnet designation 2(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- Prometheus L...ny, today announced findings from its,development ...y blood test,for irritable bowel syndrome (IBS). T...expression of particular biomarkers in blood sampl...ation of these biomarkers,combined with a proprie...
(Date:10/7/2008)... AUSTIN, Texas, Oct. 7 /- The Texa...,s Medical Center has been selected as one of,only...A-approved clinical,trial for a new device to trea...tional treatment, training and research center spe...hip between St. David,s Medical Center and,Texas C...
(Date:10/7/2008)... Study Showed Larazotide Acetate Prevented Immuno... Patients with Celiac Disease, Additional Data Ind...sease, ORLANDO, Fla., Oct. 7 /- Alba...wo clinical studies this week at the American,Coll...ic Meeting. Data from,study CLIN 1001-004, the fir...
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A ...xamining embryonic stem cell self-renewal,reporte...astim (recombinant,human serum albumin) was an eff...ell culture., The article entitled, "The ground s...ed that researchers used Cellastim as a recombinan...
Breaking Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 1Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 2Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 3Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 4Phase 1 26 2 Data of Perifosine 28KRX 0401 29 in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundat 816 1Phase 1 26 2 Data of Perifosine 28KRX 0401 29 in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundat 816 2Phase 1 26 2 Data of Perifosine 28KRX 0401 29 in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundat 816 3Phase 1 26 2 Data of Perifosine 28KRX 0401 29 in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundat 816 4Phase 1 26 2 Data of Perifosine 28KRX 0401 29 in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundat 816 5Phase 1 26 2 Data of Perifosine 28KRX 0401 29 in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundat 816 6Phase 1 26 2 Data of Perifosine 28KRX 0401 29 in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundat 816 7The structural basis of familial hypertrophic cardiomyopathy is revealed 5960 1At the root of nutrient limitation ecosystems are not as different as they seem 1160 1At the root of nutrient limitation ecosystems are not as different as they seem 1160 2At the root of nutrient limitation ecosystems are not as different as they seem 1160 3...PRNewswire-FirstCall/ -- BSD,Medical Corp. announc...zed Phase III clinical trial testing the benefit o... presented at the annual,American Society of Clini..., Illinois. According to the results of this clini...ean cancer treatment,institutions and at Duke Univ...
...RNewswire-FirstCall/ -- Boston,Scientific Corporat...n the Journal of of Cardiology (JACC) reviewing th...Company,s second-generation,TAXUS(R) Liberte(TM)(1...the April 24 edition of JACC concluded that the sh... TAXUS Liberte Stent,system compared to the TAXUS(...
Other Medicine Technology:Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 2Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 2Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 4Cross action, round handle, maximum opening 2.8 mm.
Small pupil irrigating nucleus chopper, wedge-shaped inferior edge with, blunt tip and front notch, for engaging the iris, 0.6 mm dual sideports, 20 gauge.
Irrigating nucleus chopper, 0.6 mm dual sideports, 20 gauge. For the right handed surgeon.
Karate phaco chopper, semi-sharp, wedge shaped inferior edge with a pointed tip
Medicine Products: